-
市场
-
产品
-
资讯
-
Moo社区
-
课堂
-
查看更多
-
功能介绍
-
费用费用透明,无最低余额限制
投资选择、功能介绍、费用相关信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 浅色
Isracann Adds Super Bowl MVP and Mental Health Advocate Mark Rypien to Advisory Board
Isracann Adds Super Bowl MVP and Mental Health Advocate Mark Rypien to Advisory Board
VANCOUVER, British Columbia, Aug. 23, 2022 (GLOBE NEWSWIRE) -- Isracann Biosciences Inc. (CSE: IPOT) (XFRA: A2PT0E) (OTC: ISCNF) (the "Company") a multi-faceted organization with a natural health medicine division (Praesidio Health) in Canada and holdings in Israel, is please to announce the appointment of Super Bowl XXVI MVP and mental health advocate Mr. Mark Rypien to its advisory board.
CEO Phil Floucault notes, "Mr. Rypien had a distinguished 13-year career in the NFL during which he was named to the All Madden Team in 1992, twice named to the Pro Bowl (1988 and 1991) and the first and only Canadian born Super Bowl MVP. As is widely reported and, as a result of sustained trauma during that time, Mark has suffered and continues to deal with some long-term effects. It is his advocacy for other athletes, military and civilians that brought us together. We see a synergy of working together to provide access to mental health support and to improve the mental health of all people. Whether it be our military and civilians or our athletes both professional and amateur."
Praesidio Health ( is a Canadian medical research company that develops and validates natural health products using an evidence-based process. Included in the first round of formulations submitted to Health Canada for review and approval is a product dubbed "Quiet Peace." "The trauma that I sustained from my career definitely effected my mental health," says Mark. "Back then, there were no concussion protocols. You just shook it off and kept playing. I have carried those tackles with me long after I retired. During a particularly low point in my mental wellbeing, I attempted suicide. That was a wake-up call for me. I had had enough of feeling this way. It was time to start talking about mental health."
Since then, Mark has become an advocate for athletic mental health and the mental health of our military and civilians.
"I'm excited to work with the Praesidio team to bring awareness to mental health and the potential that Praesidio products bring as part of a treatment regimen. The issues that I have dealt with and am continuing to deal with are faced by many professional athletes, military, and civilians alike. I am looking forward to helping support them," says Mark.
On Behalf of The Board of Directors
"Phil Floucault"
Phil Floucault
Chief Executive Officer and President
About Isracann Biosciences Inc. (CSE: IPOT) (XFRA: A2PT0E) (OTC: ISCNF)
Isracann is a multidisciplinary cannabis focused producer and product developer with Israeli-based cannabis production farm assets and a Canadian natural health medicine development and production arm. Concurrently focused on initial retail sales in Canada and in becoming a premier cannabis producer offering low-cost domestic Israeli production, the Company aims to commercialize natural health medicines in Canada and to leverage agreements within Israel for import/export opportunities and medicinal marijuana cultivation. For more information visit: .
Contact
Empire Communications Group
+1 (604) 343-2724
info@isracann.com
Forward-Looking Information
This release may contain forward-looking statements. Forward-looking statements are statements that are not historical facts and are generally, but not always, identified by the words "expects", "plans", "anticipates", "believes", "intends", "estimates", "projects", "potential" and similar expressions, or that events or conditions "will", "would", "may", "could" or "should" occur. Forward-looking statements may include, without limitation, statements relating to the Company's plans or goals, the Offering and the proceeds of the Offering. The forward-looking statements contained in this press release are expressly qualified in their entirety by this cautionary statement. All forward-looking statements in this press release are made as of the date of this press release. The forward-looking statements contained herein are also subject generally to assumptions and risks and uncertainties that are described from time to time in the Company's documents filed from time to time with the CSE, the British Columbia Securities Commission, the Alberta Securities Commission, and the Ontario Securities Commission. Although Isracann believes the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements are not guarantees of future performance and actual results may differ materially from those in forward looking statements. Isracann expressly disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise.
The CSE does not accept responsibility for the adequacy or accuracy of this release.
VANCOUVER, British Columbia, Aug. 23, 2022 (GLOBE NEWSWIRE) -- Isracann Biosciences Inc. (CSE: IPOT) (XFRA: A2PT0E) (OTC: ISCNF) (the "Company") a multi-faceted organization with a natural health medicine division (Praesidio Health) in Canada and holdings in Israel, is please to announce the appointment of Super Bowl XXVI MVP and mental health advocate Mr. Mark Rypien to its advisory board.
温哥华,不列颠哥伦比亚省,2022年8月23日(环球通讯社)-Isracann Biosciences Inc.(CSE:IPOT)(XFRA:A2PT0E)(场外交易:ISCNF)(The“公司)在加拿大拥有天然健康医药部门(Praesidio Health)并在以色列拥有股份的多方面组织,谨宣布任命超级碗XXVI最有价值球员、精神健康倡导者Mark Rypien先生为其顾问委员会成员。
CEO Phil Floucault notes, "Mr. Rypien had a distinguished 13-year career in the NFL during which he was named to the All Madden Team in 1992, twice named to the Pro Bowl (1988 and 1991) and the first and only Canadian born Super Bowl MVP. As is widely reported and, as a result of sustained trauma during that time, Mark has suffered and continues to deal with some long-term effects. It is his advocacy for other athletes, military and civilians that brought us together. We see a synergy of working together to provide access to mental health support and to improve the mental health of all people. Whether it be our military and civilians or our athletes both professional and amateur."
首席执行官Phil Floucault指出:“Rypien先生在NFL有13年杰出的职业生涯,在此期间,他于1992年被任命为All Madden球队成员,两次被任命为职业碗球员(1988年和1991年),也是第一位也是唯一一位出生于加拿大的超级碗MVP。正如广泛报道的那样,作为那段时间持续创伤的结果,马克遭受了一些长期影响,并将继续处理这些影响。正是他对其他运动员、军人和平民的支持让我们走到了一起。我们看到了共同努力提供心理健康支持和改善所有人的心理健康的协同作用。无论是我们的军队和平民,还是我们的运动员,无论是职业运动员还是业余运动员。
Praesidio Health ( is a Canadian medical research company that develops and validates natural health products using an evidence-based process. Included in the first round of formulations submitted to Health Canada for review and approval is a product dubbed "Quiet Peace." "The trauma that I sustained from my career definitely effected my mental health," says Mark. "Back then, there were no concussion protocols. You just shook it off and kept playing. I have carried those tackles with me long after I retired. During a particularly low point in my mental wellbeing, I attempted suicide. That was a wake-up call for me. I had had enough of feeling this way. It was time to start talking about mental health."
Praesidio Health(是一家加拿大医学研究公司,使用循证过程开发和验证天然保健品。在提交给加拿大卫生部审查和批准的第一轮配方中包括一种名为“安静的和平”的产品。“我在职业生涯中遭受的创伤肯定影响了我的心理健康,”马克说。“那时候,没有脑震荡的治疗方案。你只是摆脱它,继续比赛。在我退役很久之后,我就一直带着这些铲球。在我精神健康的特别低谷,我试图自杀。这对我来说是一个警钟。我已经受够了这种感觉。是时候开始谈论心理健康了。”
Since then, Mark has become an advocate for athletic mental health and the mental health of our military and civilians.
从那时起,马克就成了运动员心理健康和我们军民心理健康的倡导者。
"I'm excited to work with the Praesidio team to bring awareness to mental health and the potential that Praesidio products bring as part of a treatment regimen. The issues that I have dealt with and am continuing to deal with are faced by many professional athletes, military, and civilians alike. I am looking forward to helping support them," says Mark.
马克说:我很高兴能与Praesidio团队合作,让人们认识到Praesidio产品作为治疗方案的一部分所带来的心理健康和潜力。我已经处理并将继续处理的问题,许多专业运动员、军方和平民都面临着。我期待着帮助支持他们。
On Behalf of The Board of Directors
我谨代表董事会
"Phil Floucault"
《菲尔·弗洛科》
Phil Floucault
Chief Executive Officer and President
菲尔·弗洛科
首席执行官兼总裁
About Isracann Biosciences Inc. (CSE: IPOT) (XFRA: A2PT0E) (OTC: ISCNF)
Isracann is a multidisciplinary cannabis focused producer and product developer with Israeli-based cannabis production farm assets and a Canadian natural health medicine development and production arm. Concurrently focused on initial retail sales in Canada and in becoming a premier cannabis producer offering low-cost domestic Israeli production, the Company aims to commercialize natural health medicines in Canada and to leverage agreements within Israel for import/export opportunities and medicinal marijuana cultivation. For more information visit: .
Isracann Biosciences公司简介(CSE:IPOT)(XFRA:A2PT0E)(场外交易:ISCNF)
Isracann是一家专注于多学科的大麻生产商和产品开发商,拥有以色列的大麻生产农场资产和加拿大天然保健药物开发和生产部门。该公司同时专注于加拿大的初始零售,并成为提供低成本以色列国内生产的主要大麻生产商,其目标是在加拿大将天然保健药物商业化,并利用以色列境内的协议获得进出口机会和药用大麻种植。有关更多信息,请访问:。
Contact
Empire Communications Group
+1 (604) 343-2724
info@isracann.com
联系方式
帝国通信集团
+1 (604) 343-2724
邮箱:Info@isracann.com
Forward-Looking Information
This release may contain forward-looking statements. Forward-looking statements are statements that are not historical facts and are generally, but not always, identified by the words "expects", "plans", "anticipates", "believes", "intends", "estimates", "projects", "potential" and similar expressions, or that events or conditions "will", "would", "may", "could" or "should" occur. Forward-looking statements may include, without limitation, statements relating to the Company's plans or goals, the Offering and the proceeds of the Offering. The forward-looking statements contained in this press release are expressly qualified in their entirety by this cautionary statement. All forward-looking statements in this press release are made as of the date of this press release. The forward-looking statements contained herein are also subject generally to assumptions and risks and uncertainties that are described from time to time in the Company's documents filed from time to time with the CSE, the British Columbia Securities Commission, the Alberta Securities Commission, and the Ontario Securities Commission. Although Isracann believes the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements are not guarantees of future performance and actual results may differ materially from those in forward looking statements. Isracann expressly disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise.
前瞻性信息
本新闻稿可能包含前瞻性陈述。前瞻性陈述是指不是历史事实的陈述,一般但并非总是以“预期”、“计划”、“预期”、“相信”、“打算”、“估计”、“项目”、“可能”和类似的表述,或事件或条件“将”、“将”、“可能”、“可能”或“应该”发生。前瞻性陈述可能包括但不限于与公司的计划或目标、发售和发售收益有关的陈述。本新闻稿中包含的前瞻性陈述完全受本警告性声明的限制。本新闻稿中的所有前瞻性陈述都是在本新闻稿发布之日作出的。本文中包含的前瞻性陈述一般也会受到假设和风险及不确定因素的影响,这些假设和风险及不确定因素在公司不时提交给CSE、不列颠哥伦比亚省证券委员会、艾伯塔省证券委员会和安大略省证券委员会的文件中有所描述。尽管Isracann认为这些前瞻性陈述中表达的预期是基于合理的假设,但这些陈述并不能保证未来的业绩,实际结果可能与前瞻性陈述中的结果大不相同。Isracann明确表示不会因新信息、未来事件或其他原因而更新或修改任何前瞻性陈述,也不承担任何义务。
The CSE does not accept responsibility for the adequacy or accuracy of this release.
CSE不对本新闻稿的充分性或准确性承担责任。
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
风险及免责提示
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用浏览器的分享功能,分享给你的好友吧